Asian Phytoceuticals PCL's gross profit for the
three
months ended in Mar. 2026 was ฿41.8 Mil. Asian Phytoceuticals PCL's gross profit for the trailing twelve months (TTM) ended in Mar. 2026 was ฿170.4 Mil.
Asian Phytoceuticals PCL (BKK:APCO-R) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Asian Phytoceuticals PCL had a gross margin of 84.42% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Asian Phytoceuticals PCL Gross Profit Related Terms
Asian Phytoceuticals PCL Gross Profit Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:APCO-R vs PG, CL, KVUE: Gross Profit Comparison
For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asian Phytoceuticals PCL Gross Profit vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's Gross Profit distribution charts can be found below:
* The bar in red indicates where Asian Phytoceuticals PCL's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿170.4 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Asian Phytoceuticals PCL (BKK:APCO-R) has a Gross Profit of ฿170.4 Mil as of Mar. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Asian Phytoceuticals PCL and its competitors.
Is Asian Phytoceuticals PCL's Gross Profit too high?
Asian Phytoceuticals PCL's current Gross Profit is ฿170.4 Mil. Overall, Asian Phytoceuticals PCL has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's Gross Profit compare to PG and CL?
Asian Phytoceuticals PCL's Gross Profit of ฿170.4 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Consumer Packaged Goods company?
A good Gross Profit depends on the Consumer Packaged Goods industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Asian Phytoceuticals PCL and its competitors. Asian Phytoceuticals PCL's current Gross Profit is ฿170.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current Gross Profit of ฿170.4 Mil. The stock's GF Value™ is ฿7.61, compared to a current price of ฿6.27 — trading 17.6% below its estimated fair value. The current Gross Profit is ฿170.4 Mil. Asian Phytoceuticals PCL's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current Gross Profit is ฿170.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?
Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued.
The current stock price of ฿6.27 is trading 17.6% below its estimated GF Value™ of ฿7.61.
Key valuation signals for BKK:APCO-R:
Gross Profit: ฿170.4 Mil
GF Value™: ฿7.61 vs. price of ฿6.27 (17.6% below fair value)
No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
66GF Score
Get the complete analysis for BKK:APCO-R
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:APCO-R has been successfully added to your 
